An observational study in Functional Neurological Disorders, sponsored by Fondation Ophtalmologique Adolphe de Rothschild. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-28.
Sponsored by Fondation Ophtalmologique Adolphe de Rothschild · Observational
Functional neurological disorders are an important subgroup of patients with stroke mimics admitted to stroke unit.Their clinical profile and outcome are poorly known. The goal of this study is to describe the cognitive and behavioral profile of stroke mimics patients, without evidence of neurological disease.
89 studies on the registry are indexed under Conversion Disorder; 34 are open to participants now.
This study's enrollment of 40 is below the median of 60 across 37 observational studies indexed under Conversion Disorder.
Browse Conversion Disorder studies →Fondation Ophtalmologique Adolphe de Rothschild is the lead sponsor of 316 studies on the registry; 78 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients admitted in stroke unit for a neurological deficit, without evidence of neurovascular or othe neurological disease
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients
Other: Description
description of the cognitive and behavioral profile of stroke mimics patients, without evidence of neurological disease.
Patient characteristics
Cognitive/behavioural characteristics of patients assessed for stroke using the National Institute of Health Stroke Score ranging from 0 to 42 (0: no stroke; 1-4: minor stroke; 5-15: moderate stroke; moderate to severe stroke; 21-42: severe stroke)
Time frame: 3 months
symptoms of patients
Description of symptoms at 3 and 6 months after transition in stroke unit
Time frame: 3 and 6 months
Ran from Mar 2021 to primary completion in Oct 2025, 55 months.
Of 16 observational studies under Conversion Disorder, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 55. This study's 55 months is above that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondation Ophtalmologique Adolphe de Rothschild →